Literature DB >> 25167680

[Progress on bone marrow mesenchymal stem cells transplantation for spinal cord injury].

Li Wang, Qian Wang, Xiao-Ming Zhang.   

Abstract

Bone marrow mesenchymal cells (BMSCs) are regarded as donor cells in cell transplantation therapies for spinal cord injury (SCI) for they have the ability of favourable proliferation and multi-directional differentiation, and are easily isolated and culturd and have less immunological reaction. It has been confirmed that subarachnoid space injection is the most ideal delivery technique of BMSCs. Bone marrow mesenchymal stem cells transplantation is safe and its reconditioning role is certain for SCI in early clinical application. The mechanism of BMSCs promoting functional recovery after SCI is probably concerned with vicarious function, nerve trophism, immunosuppression and promoting axonal regeneration by BMSCs.

Entities:  

Mesh:

Year:  2014        PMID: 25167680

Source DB:  PubMed          Journal:  Zhongguo Gu Shang        ISSN: 1003-0034


  3 in total

Review 1.  Progress in Stem Cell Therapy for Spinal Cord Injury.

Authors:  Liansheng Gao; Yucong Peng; Weilin Xu; Pingyou He; Tao Li; Xiaoyang Lu; Gao Chen
Journal:  Stem Cells Int       Date:  2020-11-05       Impact factor: 5.443

2.  Bone marrow mesenchymal stem cells stimulated with low-intensity pulsed ultrasound: Better choice of transplantation treatment for spinal cord injury: Treatment for SCI by LIPUS-BMSCs transplantation.

Authors:  Guang-Zhi Ning; Wen-Ye Song; Hong Xu; Ru-Sen Zhu; Qiu-Li Wu; Yu Wu; Shi-Bo Zhu; Ji-Qing Li; Man Wang; Zhi-Gang Qu; Shi-Qing Feng
Journal:  CNS Neurosci Ther       Date:  2018-10-08       Impact factor: 5.243

3.  miR-134 inhibits chondrogenic differentiation of bone marrow mesenchymal stem cells by targetting SMAD6.

Authors:  Shaogang Xu; Xuejian Wu
Journal:  Biosci Rep       Date:  2019-01-30       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.